| Literature DB >> 36204116 |
Soufyane Lafraxo1, Abdelfattah El Moussaoui1, Yousef A Bin Jardan2, Azeddin El Barnossi1, Mohamed Chebaibi3, Soukayna Baammi4, Aziz Ait Akka5, Khalid Chebbac5, Mohamed Akhazzane6, Tarik Chelouati7, Hiba-Allah Nafidi8, Khallouki Farid9, Mohammed Bourhia10, Amina Bari1.
Abstract
Juniperus thurifera is a native species to the mountains of the western Mediterranean region. It is used in traditional medicine as a natural treatment against infections. The present study aimed to carry out the chemical analysis and evaluate the antioxidant, antimicrobial, as well as in silico inhibition studies of the essential oils from Juniperus thurifera bark (EOEJT). Chemical characterization of EOEJT was done by gas chromatography (GC-MS). We have performed three antioxidant assays (Reducing power (FRAP), 2, 2-diphenylpicrylhydrazyl (DPPH), and total antioxidant capacity (TAC)) of the EOEJT. We next evaluated the antimicrobial activity against in silico study, which was carried out to help evaluate the inhibitory effect of EOEJT against NADPH oxidase. Results of the GC/MS analysis revealed seven major compounds in EOEJT wherein muurolol (36%) and elemol (26%) were the major components. Moreover, EOEJT possessed interesting antioxidant potential with an IC50 respectively of 21.25 ± 1.02 μg/mL, 481.02 ± 5.25 μg/mL, and 271 μg EAA/mg in DPPH, FRAP, and total antioxidant capacity systems. Molecular docking of EOEJT in NADPH oxidase active site showed inhibitory activity of α-cadinol and muurolol with a glide score of -6.041 and -5.956 Kcal/mol, respectively. As regards the antibacterial and antifungal capacities, EOEJT was active against all tested bacteria and all fungi, notably, against Escherichia coli K12 with an inhibition diameter of 21 mm and a MIC value of 0.67 mg/mL, as well as against Proteus mirabilis ATCC 29906 with an inhibition diameter of 18.33 ± 1.15 mm and a MIC value of 1.34 mg/mL. A more pronounced effect was recorded for the fungal pathogens Fusarium oxysporum MTCC 9913 with inhibition of 37.44 ± 0.28% and MIC value of 6.45 mg/mL, as well as against Candida albicans ATCC 10231 with an inhibition diameter of 20.33 ± 1.15 mm and a MIC value of 0.67 ± 0.00 mg/mL. Altogether, these results highlight the importance of EOEJT as a source of natural antibacterial and antioxidant drugs to fight clinically important pathogenic strains.Entities:
Year: 2022 PMID: 36204116 PMCID: PMC9532082 DOI: 10.1155/2022/6305672
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.650
Figure 1Photograph of Juniperus thurifera.
Figure 2Gas chromatographic profile of EOEJT by GC/MS.
Tabulation of the GC-MS analysis of EOEJT.
| Peaks | RT | Name | Area (%) | Calculated RI | Literature RI | Molecular structure |
|---|---|---|---|---|---|---|
| 1 | 8.36 |
| 14.76 | 948 | 939 |
|
| 2 | 29.26 | Elemol | 26.93 | 1528 | 1529 |
|
| 3 | 31.72 |
| 5.23 | 1664 | 1662 |
|
| 4 | 32.05 |
| 4.42 | 1650 | 1654 |
|
| 5 | 32.37 | Muurolol | 36.31 | 1640 | 1642 |
|
| 6 | 33.61 | Eicosane | 4.55 | 2007 | 2009 |
|
| 7 | 37.02 | Cryptomeridiol | 7.78 | 1811 | 1813 |
|
| Total 99.98% | ||||||
Figure 3(a, b) Antioxidant capacity using DPPH, (c, d) FRAP method, (e) and total antioxidant capacity.
Figure 4The antibacterial capacity for EOEJT on solid media (disc diffusion method).
Figure 5The antibacterial capacity of EOEJT in a solid medium (disc diffusion method), (means ± SD, n = 3) marked with the same letter for each strain indicated no significant difference at p ≤ 0.05.
antibacterial capacity of EOEJT in a liquid medium (microdilution method).
|
|
|
|
| |
|---|---|---|---|---|
| EOEJT | 1.34 ± 0,00a | 0.67 ± 0.00a | 2.69 ± 0.00a | 1.34 ± 0.00a |
| Erythromycin | −b | 3.125 ± 0.00b | −b | 3.125 ± 0.00b |
| DMSO 10% | −b | −c | −b | −c |
(Mean ± SD, n = 3) with different letters in the same column are significantly different (Tow-way ANOVA; Tukey's test, p ≤ 0.05).
Figure 6The antifungal capacity for EOEJT on solid media (disc method).
antifungal activity of EOEJT.
| Candida albicans ATCC 10231 | Aspergillus niger MTCC 282 | Aspergillus flavus MTCC 9606 | Fusarium oxysporum MTCC 9913 | |||||
|---|---|---|---|---|---|---|---|---|
| Antifungal activity (mm) | MIC (mg/mL) | Antifungal activity (%) | MIC (mg/mL) | Antifungal activity (%) | MIC (mg/mL) | Antifungal activity (%) | MIC (mg/mL) | |
| EOEJT | 20.33 ± 1.15a | 0.67 ± 0.00a | 21.39 ± 0.57a | 10.75 ± 0.00a | 0.00 ± 0.00a | −a | 37.44 ± 0.28a | 6.45 ± 0.00a |
| Fluconazole | 13.00 ± 1.00b | 7.50 ± 0.00b | 21.33 ± 1.53a | 7.5 ± 0.00b | 0.00 ± 0.00a | −a | 30 ± 0.50b | 7.5 ± 0.00a |
| DMSO 10% | 0.00 ± 0.00c | −c | 0.00 ± 0.00b | −c | 0.00 ± 0.00a | −a | 0.00 ± 0.00c | −b |
(Mean ± SD, n = 3) with different letters in the same column are significantly different (Tow-way ANOVA; Tukey's test, p ≤ 0.05).
Figure 7Principal component analysis (PCA) in the C1-C2 plane presents the correlations of antimicrobial activity of EOEJT compared to erythromycin and fluconazole. Ag. A. niger; Af: A. flavus; Fo: F. oxysporum; Ca: C. albicans; Sa: S. aureus; Ec: E. coli; Bs: B. subtilis; Pm: P. mirabilis.
Docking results of EOEJT in the active site of NADPH.
| Glide Gscore | Glide emodel | Glide energy | |
|---|---|---|---|
|
| −6.041 | −39.399 | −28.218 |
| Muurolol | −5.956 | −40.689 | −28.987 |
|
| −5.542 | −34.926 | −26.230 |
| Elemol | −4.538 | −34.725 | −26.235 |
|
| −4.358 | −20.490 | −16.077 |
Figure 82D diagrams of ligands interactions with the active site of NADPH. (a) α-Cadinol; (b) muurolol; (c) γ-eudesmol; (d) elemol.
Figure 93D diagrams of ligands' interactions with the active site of NADPH. (a) α-Cadinol; (b) muurolol; (c) γ-eudesmol; (d) Elemol.